Paper Title

ENHANCING SAFER PRESCRIPTIONS FOR SENIORS: A CROSS-SECTIONAL STUDY ON THE EVALUATION OF PRESCRIPTION PATTERN AND CHANCES OF PRESCRIBING POTENTIALLY INAPPROPRIATE MEDICATIONS IN GERIATRIC PATIENTS USING 'AGS BEERS CRITERIA 2019'

Article Identifiers

Registration ID: IJNRD_211234

Published ID: IJNRD2312335

DOI: Click Here to Get

Authors

DEVARAJ A , KEERTHI R , MADHAN V , M NAVEEN KRISHNA , LIJI JOY M

Keywords

Keywords: AGS Beer’s criteria, older adults, potentially inappropriate medication (PIM), safer prescription, Good prescription practice, Geriatric care

Abstract

ABSTRACT Objective: This study aimed to assess the prescribing pattern and frequency of potentially inappropriate medications (PIMs) in geriatrics based on the AGS Beers Criteria 2019. Methods: With an aim to Contributing to elderly healthcare improvement, a six-month prospective cross-sectional study was conducted in a tertiary healthcare center from May to October 2022. The sample included 108 hospitalized patients, regardless of gender, each prescribed at least one medicine. Using the AGS Beers Criteria as a reference, the study team extracted information from patient records for prescription analysis, and the collected data were analyzed using Statistical Package for Social Sciences (SPSS). Results: Among the 108 participants, 61.11% were men, and 38.89% were women, with the majority (45.37%) in the 65-69 age group. Of the 815 medications examined, 10.67% were potentially inappropriate. There were 56.32%, 0%, 33.33%, 1.15%, and 9.2% PIMs in Category I, II, III, IV, and V of Beer’s criteria respectively. Insulin, Glimepiride, and Furosemide was the most frequently prescribed PIMs.. Logistic regression revealed a significant association between the likelihood of prescribing PIMs with the number of comorbidities (OR: 0.042, 95% CI: 1.018 to 2.827, p=0.42) and the number of drugs (OR: 1.204, 95% CI: 1.015 to 1.429, p=0.33). Conclusion: This study emphasizes the need for vigilance in prescription practices for geriatric patients. Identifying commonly prescribed PIMs and re-evaluating them, considering co-morbidities and the number of drugs prescribed, are crucial steps to enhance appropriateness and quality of care for geriatric patients.

How To Cite (APA)

DEVARAJ A, KEERTHI R, MADHAN V, M NAVEEN KRISHNA, & LIJI JOY M (December-2023). ENHANCING SAFER PRESCRIPTIONS FOR SENIORS: A CROSS-SECTIONAL STUDY ON THE EVALUATION OF PRESCRIPTION PATTERN AND CHANCES OF PRESCRIBING POTENTIALLY INAPPROPRIATE MEDICATIONS IN GERIATRIC PATIENTS USING 'AGS BEERS CRITERIA 2019'. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(12), d321-d332. https://ijnrd.org/papers/IJNRD2312335.pdf

Issue

Volume 8 Issue 12, December-2023

Pages : d321-d332

Other Publication Details

Paper Reg. ID: IJNRD_211234

Published Paper Id: IJNRD2312335

Downloads: 000121979

Research Area: Pharmacy

Country: Bengaluru, Karnataka, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2312335.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2312335

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details